These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 11251885)
1. Administration of BiMAb-retargeted T cells in a rat hepatic metastases colon tumour model results in T-cell tumour infiltration independent of the route of administration. Koelemij R; Hagenaars M; Ensink NG; Eggermont AM; Van De Velde CJ; Fleuren GJ; Kuppen PJ Scand J Immunol; 2001 Mar; 53(3):277-81. PubMed ID: 11251885 [TBL] [Abstract][Full Text] [Related]
2. The development of a bi-specific anti-CD161A x anti-tumor antibody for rat NK cell targeting. Hagenaars M; Ensink NG; Jonges LE; Chambers WH; Eggermont AM; van de Velde CJ; Fleuren GJ; Kuppen PJ Immunobiology; 1999 Feb; 200(1):31-48. PubMed ID: 10084694 [TBL] [Abstract][Full Text] [Related]
3. The development and purification of a bispecific antibody for lymphokine-activated killer cell targeting against the rat colon carcinoma CC531. Kuppen PJ; Eggermont AM; Smits KM; van Eendenburg JD; Lazeroms SP; van de Velde CJ; Fleuren GJ Cancer Immunol Immunother; 1993 Jun; 36(6):403-8. PubMed ID: 8500112 [TBL] [Abstract][Full Text] [Related]
4. Regional administration of natural killer cells in a rat hepatic metastasis model results in better tumor infiltration and anti-tumor response than systemic administration. Hagenaars M; Ensink NG; Koelemij R; Basse PH; Eggermont AM; van de Velde CJ; Fleuren GJ; Kuppen PJ Int J Cancer; 1998 Jan; 75(2):233-8. PubMed ID: 9462713 [TBL] [Abstract][Full Text] [Related]
5. The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin-2-activated natural killer cells in Wag rats. Kuppen PJ; Basse PH; Goldfarb RH; Van De Velde CJ; Fleuren GJ; Eggermont AM Int J Cancer; 1994 Feb; 56(4):574-9. PubMed ID: 8112894 [TBL] [Abstract][Full Text] [Related]
6. Biodistribution of lymphokine-activated killer (LAK) cells in Wag rats after hepatic-artery or jugular-vein infusion. Kuppen PJ; Marinelli A; Camps JA; Pauwels EK; van de Velde CJ; Fleuren GJ; Eggermont AM Int J Cancer; 1992 Sep; 52(2):266-70. PubMed ID: 1521913 [TBL] [Abstract][Full Text] [Related]
7. T-cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model: IV. Tumor neutralization in Winn type assays. Beun GD; van de Velde CJ; Fleuren GJ; Eggermont AM J Immunother Emphasis Tumor Immunol; 1993 Jul; 14(1):11-5. PubMed ID: 8399065 [TBL] [Abstract][Full Text] [Related]
8. Characteristics of tumor infiltration by adoptively transferred and endogenous natural-killer cells in a syngeneic rat model: implications for the mechanism behind anti-tumor responses. Hagenaars M; Zwaveling S; Kuppen PJ; Ensink NG; Eggermont AM; Hokland ME; Basse PH; van de Velde CJ; Fleuren GJ; Nannmark U Int J Cancer; 1998 Dec; 78(6):783-9. PubMed ID: 9833773 [TBL] [Abstract][Full Text] [Related]
9. Use of anti-CD3 and anti-CD16 bispecific monoclonal antibodies for the targeting of T and NK cells against tumor cells. Ferrini S; Cambiaggi A; Sforzini S; Canevari S; Mezzanzanica D; Colnaghi MI; Moretta L Cancer Detect Prev; 1993; 17(2):295-300. PubMed ID: 8402715 [TBL] [Abstract][Full Text] [Related]
10. The development of novel mouse monoclonal antibodies against the CC531 rat colon adenocarcinoma. Hagenaars M; Koelemij R; Ensink NG; van Eendenburg JD; van Vlierberghe RL; Eggermont AM; van de Velde CJ; Fleuren GJ; Kuppen PJ Clin Exp Metastasis; 2000; 18(4):281-9. PubMed ID: 11448057 [TBL] [Abstract][Full Text] [Related]
11. Role of sialyl Lewis X in liver metastasis in view of liver-associated immunity. Okuno K; Kawai I; Hirai N; Narimatsu H; Yasutomi M Hepatogastroenterology; 2003; 50(51):756-60. PubMed ID: 12828079 [TBL] [Abstract][Full Text] [Related]
12. Bispecific monoclonal antibodies directed to CD16 and to a tumor-associated antigen induce target-cell lysis by resting NK cells and by a subset of NK clones. Ferrini S; Prigione I; Miotti S; Ciccone E; Cantoni C; Chen Q; Colnaghi MI; Moretta L Int J Cancer; 1991 May; 48(2):227-33. PubMed ID: 1826900 [TBL] [Abstract][Full Text] [Related]
13. Targeting of T lymphocytes against EGF-receptor+ tumor cells by bispecific monoclonal antibodies: requirement of CD3 molecule cross-linking for T-cell activation. Ferrini S; Cambiaggi A; Sforzini S; Marciano S; Canevari S; Mezzanzanica D; Colnaghi MI; Grossi CE; Moretta L Int J Cancer; 1993 Dec; 55(6):931-7. PubMed ID: 8253530 [TBL] [Abstract][Full Text] [Related]
14. Uptake of long-circulating immunoliposomes, directed against colon adenocarcinoma cells, by liver metastases of colon cancer. Kamps JA; Koning GA; Velinova MJ; Morselt HW; Wilkens M; Gorter A; Donga J; Scherphof GL J Drug Target; 2000; 8(4):235-45. PubMed ID: 11144234 [TBL] [Abstract][Full Text] [Related]
15. T cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. II. Syngeneic colon carcinoma CC531 is efficiently killed by retargeted cytotoxic T lymphocytes in vitro despite limited lysis in 51Cr release assays. Beun GD; Gorter A; Nooyen Y; van de Velde CJ; Fleuren GJ J Immunol; 1993 Mar; 150(6):2305-15. PubMed ID: 8450213 [TBL] [Abstract][Full Text] [Related]
16. Macrophage populations in different stages of induced hepatic metastases in rats: an immunohistochemical analysis. Heuff G; van der Ende MB; Boutkan H; Prevoo W; Bayon LG; Fleuren GJ; Beelen RH; Meijer S; Dijkstra CD Scand J Immunol; 1993 Jul; 38(1):10-6. PubMed ID: 8327856 [TBL] [Abstract][Full Text] [Related]
17. Role of NK and T cells in IL-12-induced anti-tumor response against hepatic colon carcinoma. Pham-Nguyen KB; Yang W; Saxena R; Thung SN; Woo SL; Chen SH Int J Cancer; 1999 May; 81(5):813-9. PubMed ID: 10328238 [TBL] [Abstract][Full Text] [Related]
18. Effects of cyclosporine A on experimental hepatic metastases of mouse colon-26 tumour. Suzaki N; Fuchimoto S; Iwagaki H; Orita K J Int Med Res; 1995; 23(2):112-8. PubMed ID: 7601293 [TBL] [Abstract][Full Text] [Related]